ArticleAAPS PharmSciTech2025
Generative Model Enhanced X-ray Computed Tomography Imaging for Pharmaceutical Powder Microstructure Reconstruction and Evaluation.
Article in AAPS PharmSciTech, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Microstructural characteristics and particle interactions are pivotal in pharmaceutical manufacturing processes, fundamentally influencing performance such as flowability and dissolution. Variations in microstructural arrangements, even with identical compositions, can contribute to different process performance and product quality. Traditional methods rely on empirical experiments or physical simulations, which are prone to information loss and time-consuming. In this research, an innovative production framework is introduced, including a generative model S2V-GAN (Slice to Volume GAN) with quantitative evaluation metrics and a learning-based flowability prediction model. Specifically, the S2V-GAN consists of a U-net generator and a 2D Slice discriminator using Wasserstein strategy for generating synthetic microstructures that achieve time reduction and rich digital microstructure data through different X-ray Computed Tomography (XCT) scanning scenarios. The prediction model trained with the particle morphology-flow pairing database predicts the flowability of granular medicines through some morphological parameters. The generative model reconstructed the microstructure of single or binary particles by limited training slices and achieved high-level similarity in the distribution of morphological parameters during evaluation. By using the data set to train and fit the flow prediction model, a higher accuracy was achieved in the test, thus realizing the complete process from structure generation to flowability prediction. Finally, the production framework successfully reconstructs and augments high-fidelity three-dimensional microstructures, enabling efficient structural analysis and process optimization.
Indexed as
Identifiers
41254437What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.